CEMIP and cancer: Targeting CEMIP hyaluronidase activity with therapeutic small molecule inhibitors may therefore be an efficacious method to promote repair following CNS insults, reduce cancer cell metastasis to the brain, and reverse other pathological conditions linked to elevated HA catabolism.